Sharing individual level data from observational studies and clinical trials: a perspective from NHLBI

被引:36
|
作者
Coady, Sean A. [1 ]
Wagner, Elizabeth [2 ]
机构
[1] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA
[2] Div Blood Dis & Resources, Bethesda, MD USA
来源
TRIALS | 2013年 / 14卷
关键词
Data sharing; Clinical trials; Cohort studies; HIPAA; OPEN SCIENCE; RAW DATA; PRIVACY; ACCESS;
D O I
10.1186/1745-6215-14-201
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There are numerous benefits to the research community from data sharing, and yet the open sharing of participant level data is not without potential pitfalls. In addition to the scientific community, the interests of study participants who volunteered their data must be considered, along with the interests of study investigators who expend a substantial amount of effort into the design, conduct, and analytical plans for the study. The National Heart, Lung, and Blood Institute (NHLBI) has developed a data-sharing protocol focused on balancing the interests of study participants, study investigators, and the research community with independent oversight by the NHLBI IRB. The data repository presently includes individual level data on more than 560,000 participants from 100 Institute-supported clinical trials and observational studies.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] The European Medicines Agency's plans for sharing data from clinical trials
    Groves, Trish
    Godlee, Fiona
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [42] Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19
    Esmail, Laura C.
    Kapp, Philipp
    Assi, Rouba
    Wood, Julie
    Regan, Gabriela
    Ravaud, Philippe
    Boutron, Isabelle
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (19): : 1695 - 1697
  • [43] Nutrient effects: Discrepancy between data from controlled trials and observational studies
    Heaney, RP
    [J]. BONE, 1997, 21 (06) : 469 - 471
  • [44] Dose of dialysis: Key lessons from major observational studies and clinical trials
    Saran, R
    Canaud, BJ
    Depner, TA
    Keen, ML
    McCullough, KP
    Marshall, MR
    Port, FK
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (05) : S47 - S53
  • [45] Nicotine replacement therapy: evidence from observational studies versus clinical trials
    George, Johnson
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (06) : 383 - 383
  • [47] Detecting data fabrication in clinical trials from cluster analysis perspective
    Wu, Xiaoru
    Carlsson, Martin
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (03) : 257 - 264
  • [48] Levofloxacin safety: data from clinical trials and pharmacovigilance studies
    Carbon, C
    [J]. THERAPIE, 2001, 56 (01): : 35 - 40
  • [49] From Randomized Controlled Trials to Observational Studies
    Silverman, Stuart L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (02): : 114 - 120
  • [50] Access to Patient-Level Data from GlaxoSmithKline Clinical Trials
    Nisen, Perry
    Rockhold, Frank
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05): : 475 - 478